Indications

• xxx

---

Pharmacology

• Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor (see Sodium-Glucose Cotransporter-2 Inhibitors)

Metabolism

• xxxx

---

Administration

• IV:

Dose Adjusmtment

• Hepatic
• Renal

---

Adverse Effects

• xxx

---

References

• xxx